Literature DB >> 21740328

Septin roles in tumorigenesis.

Diana Connolly1, Ines Abdesselam, Pascal Verdier-Pinard, Cristina Montagna.   

Abstract

Septins are a family of cytoskeleton related proteins consisting of 14 members that associate and interact with actin and tubulin. From yeast to humans, septins maintain a conserved role in cytokinesis and they are also involved in a variety of other cellular functions including chromosome segregation, DNA repair, migration and apoptosis. Tumorigenesis entails major alterations in these processes. A substantial body of literature reveals that septins are overexpressed, downregulated or generate chimeric proteins with MLL in a plethora of solid tumors and in hematological malignancies. Thus, members of this gene family are emerging as key players in tumorigenesis. The analysis of septins during cancer initiation and progression is challenged by the presence of many family members and by their potential to produce numerous isoforms. However, the development and application of advanced technologies is allowing for a more detailed analysis of septins during tumorigenesis. Specifically, such applications have led to the establishment and validation of SEPT9 as a biomarker for the early detection of colorectal cancer. This review summarizes the current knowledge on the role of septins in tumorigenesis, emphasizing their significance and supporting their use as potential biomarkers in various cancer types.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21740328     DOI: 10.1515/BC.2011.073

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  43 in total

Review 1.  The emerging functions of septins in metazoans.

Authors:  Juha Saarikangas; Yves Barral
Journal:  EMBO Rep       Date:  2011-10-28       Impact factor: 8.807

Review 2.  Septin functions in organ system physiology and pathology.

Authors:  Lee Dolat; Qicong Hu; Elias T Spiliotis
Journal:  Biol Chem       Date:  2014-02       Impact factor: 3.915

3.  An 80-gene set to predict response to preoperative chemoradiotherapy for rectal cancer by principle component analysis.

Authors:  Shinichiro Empuku; Kentaro Nakajima; Tomonori Akagi; Kunihiko Kaneko; Naoki Hijiya; Tsuyoshi Etoh; Norio Shiraishi; Masatsugu Moriyama; Masafumi Inomata
Journal:  Mol Clin Oncol       Date:  2016-03-07

Review 4.  [Functional Characterization of Septin Complexes].

Authors:  K A Akhmetova; I N Chesnokov; S A Fedorova
Journal:  Mol Biol (Mosk)       Date:  2018 Mar-Apr

5.  Septin oligomerization regulates persistent expression of ErbB2/HER2 in gastric cancer cells.

Authors:  Elizabeth A Marcus; Elmira Tokhtaeva; Shahlo Turdikulova; Joseph Capri; Julian P Whitelegge; David R Scott; George Sachs; Fedor Berditchevski; Olga Vagin
Journal:  Biochem J       Date:  2016-04-05       Impact factor: 3.857

Review 6.  Septins: the fourth component of the cytoskeleton.

Authors:  Serge Mostowy; Pascale Cossart
Journal:  Nat Rev Mol Cell Biol       Date:  2012-02-08       Impact factor: 94.444

7.  Preparing recombinant yeast septins and their analysis by electron microscopy.

Authors:  A Bertin; E Nogales
Journal:  Methods Cell Biol       Date:  2016-04-14       Impact factor: 1.441

8.  A multi-omics study links TNS3 and SEPT7 to long-term former smoking NSCLC survival.

Authors:  Sipeng Shen; Yongyue Wei; Yi Li; Weiwei Duan; Xuesi Dong; Lijuan Lin; Dongfang You; Adonina Tardon; Chu Chen; John K Field; Rayjean J Hung; Geoffrey Liu; Dakai Zhu; Christopher I Amos; Li Su; Yang Zhao; Zhibin Hu; Hongbing Shen; Ruyang Zhang; Feng Chen; David C Christiani
Journal:  NPJ Precis Oncol       Date:  2021-05-17

9.  Steps solidifying a role for SEPT9 in breast cancer suggest that greater strides are needed.

Authors:  Laura Stanbery; Elizabeth M Petty
Journal:  Breast Cancer Res       Date:  2012-01-09       Impact factor: 6.466

10.  Lentiviral expression of anti-microRNAs targeting miR-27a inhibits proliferation and invasiveness of U87 glioma cells.

Authors:  Su Y Feng; Chang G Dong; William K K Wu; Xiao J Wang; Jian Qiao; Jun F Shao
Journal:  Mol Med Rep       Date:  2012-05-15       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.